![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ||
Founding Date | Founding Date 1896 | Founding Date 1996 | Founding Date 1849 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | |
Employees | Employees 103,249 | Employees 75,883 | Employees 81,0008% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods CHF13.1b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit CHF50.5b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) |
Net income | Net income CHF13.8b (FY, 2025) | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | |||
Patients | Patients 22.8 m (FY, 2023) | Patients 10 m (FY, 2022) | Patients N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 7.8b | Total funding raised $ 6.5m | Total funding raised N/A |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company